These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26310861)

  • 1. Long-term outcome in pyridoxine-responsive infantile epilepsy.
    Riikonen R; Mankinen K; Gaily E
    Eur J Paediatr Neurol; 2015 Nov; 19(6):647-51. PubMed ID: 26310861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome.
    Mills PB; Camuzeaux SS; Footitt EJ; Mills KA; Gissen P; Fisher L; Das KB; Varadkar SM; Zuberi S; McWilliam R; Stödberg T; Plecko B; Baumgartner MR; Maier O; Calvert S; Riney K; Wolf NI; Livingston JH; Bala P; Morel CF; Feillet F; Raimondi F; Del Giudice E; Chong WK; Pitt M; Clayton PT
    Brain; 2014 May; 137(Pt 5):1350-60. PubMed ID: 24645144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy.
    Wang HS; Kuo MF; Chou ML; Hung PC; Lin KL; Hsieh MY; Chang MY
    Arch Dis Child; 2005 May; 90(5):512-5. PubMed ID: 15851435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of pyridoxine in early-onset idiopathic intractable seizures in children.
    Mishra D; Kalra V; Seth R; Gulati S; Saha N
    Indian J Pediatr; 2010 Nov; 77(11):1252-6. PubMed ID: 20830535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of pyridoxine to prednisolone in the treatment of infantile spasms: A pilot, randomized controlled trial.
    Kunnanayaka V; Jain P; Sharma S; Seth A; Aneja S
    Neurol India; 2018; 66(2):385-390. PubMed ID: 29547159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up.
    Stockler S; Plecko B; Gospe SM; Coulter-Mackie M; Connolly M; van Karnebeek C; Mercimek-Mahmutoglu S; Hartmann H; Scharer G; Struijs E; Tein I; Jakobs C; Clayton P; Van Hove JL
    Mol Genet Metab; 2011; 104(1-2):48-60. PubMed ID: 21704546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal status epilepticus as atypical presentation of pyridoxine-dependent epilepsy.
    Yoshii A; Takeoka M; Kelly PJ; Krishnamoorthy KS
    J Child Neurol; 2005 Aug; 20(8):696-8. PubMed ID: 16225819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics and prognosis analysis of vitamin B6 responsive infantile spasms].
    Xue J; Yang Z; Wu Y; Xiong H; Zhang Y; Liu X
    Zhonghua Er Ke Za Zhi; 2016 Feb; 54(2):141-4. PubMed ID: 26875466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of infantile spasms with high-dosage vitamin B6.
    Pietz J; Benninger C; Schäfer H; Sontheimer D; Mittermaier G; Rating D
    Epilepsia; 1993; 34(4):757-63. PubMed ID: 8330589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Rare Presentation Characterized by Epileptic Spasms in
    Jiao X; Gong P; Niu Y; Zhang Y; Yang Z
    Front Genet; 2022; 13():804461. PubMed ID: 35495162
    [No Abstract]   [Full Text] [Related]  

  • 11. Infantile Spasms without Hypsarrhythmia and Paroxysmal Eye-Head Movements in an Infant with a Pyridoxine-Dependent Epilepsy due to PLPBP/PLPHP Deficiency.
    Kalser J; Giuliano F; Peralta M; Plecko B; Bölsterli BK
    Neuropediatrics; 2023 Dec; 54(6):422-425. PubMed ID: 36577449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seizures and paroxysmal events: symptoms pointing to the diagnosis of pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency.
    Schmitt B; Baumgartner M; Mills PB; Clayton PT; Jakobs C; Keller E; Wohlrab G
    Dev Med Child Neurol; 2010 Jul; 52(7):e133-42. PubMed ID: 20370816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of two cohorts of infantile spasms: response to pyridoxine or topiramate monotherapy.
    Xue J; Qian P; Li H; Wu Y; Xiong H; Zhang YH; Yang ZX
    World J Pediatr; 2018 Jun; 14(3):290-297. PubMed ID: 29700769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin B6 related epilepsy during childhood.
    Wang HS; Kuo MF
    Chang Gung Med J; 2007; 30(5):396-401. PubMed ID: 18062169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyridoxine-dependent epilepsy initially responsive to phenobarbital.
    Lin J; Lin K; Masruha MR; Vilanova LC
    Arq Neuropsiquiatr; 2007 Dec; 65(4A):1026-9. PubMed ID: 18094870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene.
    Baumgartner-Sigl S; Haberlandt E; Mumm S; Scholl-Bürgi S; Sergi C; Ryan L; Ericson KL; Whyte MP; Högler W
    Bone; 2007 Jun; 40(6):1655-61. PubMed ID: 17395561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyridoxine or pyridoxal-5-phosphate treatment for seizures in glycosylphosphatidylinositol deficiency: A cohort study.
    Bayat A; Aledo-Serrano A; Gil-Nagel A; Korff CM; Thomas A; Boßelmann C; Weber Y; Gardella E; Lund AM; de Sain-van der Velden MGM; Møller RS
    Dev Med Child Neurol; 2022 Jun; 64(6):789-798. PubMed ID: 35080266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folinic acid-responsive seizures initially responsive to pyridoxine.
    Nicolai J; van Kranen-Mastenbroek VH; Wevers RA; Hurkx WA; Vles JS
    Pediatr Neurol; 2006 Feb; 34(2):164-7. PubMed ID: 16458834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridoxine-5'-phosphate oxidase (Pnpo) deficiency: Clinical and biochemical alterations associated with the C.347g>A (P.·Arg116gln) mutation.
    di Salvo ML; Mastrangelo M; Nogués I; Tolve M; Paiardini A; Carducci C; Mei D; Montomoli M; Tramonti A; Guerrini R; Contestabile R; Leuzzi V
    Mol Genet Metab; 2017 Sep; 122(1-2):135-142. PubMed ID: 28818555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple therapy with pyridoxine, arginine supplementation and dietary lysine restriction in pyridoxine-dependent epilepsy: Neurodevelopmental outcome.
    Coughlin CR; van Karnebeek CD; Al-Hertani W; Shuen AY; Jaggumantri S; Jack RM; Gaughan S; Burns C; Mirsky DM; Gallagher RC; Van Hove JL
    Mol Genet Metab; 2015; 116(1-2):35-43. PubMed ID: 26026794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.